Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Several lines of evidence suggest a dysfunctional glutamate system in major depressive disorder (MDD). Recently, we reported reduced levels of metabotropic glutamate receptor subtype 5 (mGluR5) in postmortem brains in MDD, however the neurobiological mechanisms that induce these abnormalities are unclear. In the present study, we examined the effect of chronic corticosterone (CORT) administration on the expression of mGluR5 protein and mRNA in the rat frontal cortex and hippocampus. Rats were injected with CORT (40 mg/kg, s.c.) or vehicle once daily for 21 days. The expression of mGluR5 protein and mRNA was assessed by Western blotting and quantitative real-time PCR. In addition, mGluR1 protein was measured in the same animals. The results revealed that while there was a significant reduction (− 27 %, p=0.0006) in mGluR5 protein expression in the hippocampus from CORT treated rats, mRNA levels were unchanged. Also unchanged were mGluR5 mRNA and protein levels in the frontal cortex and mGluR1 protein levels in both brain regions. Our findings provide the first evidence that chronic CORT exposure regulates the expression of mGluR5 and are in line with previous postmortem and imaging studies showing reduced mGluR5 in MDD. Our findings suggest that elevated levels of glucocorticoids may contribute to impairments in glutamate neurotransmission in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“These data suggest that elevated cortisol levels could contribute to glutamate system abnormalities in MDD and is consistent with the fact that 50–80% of severely depressed patients show a significant hyperactivity of the HPA axis (Holsboer, 2000; Pariante and Miller, 2001).”
ResultTargeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Magarin˜os, A. M., & McEwen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00259-l · Cited by 863 · cited 1×
“Overall, the CORT-induced reductions in adrenal and body weights seen in our paradigm are consistent with previous studies demonstrating the effects of glucocorticoids, and support the effectiveness of the CORT dose used in our experiments (Marks et al., 2009; Magarinos and McEwen, 1995).”
ResultKarst, H., Berger, S., Turiault, M., Tronche, F., Schütz, G., & Joëls, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507572102 · Cited by 774
Wellman, C. L. (2001) · Journal of Neurobiology · doi:10.1002/neu.1079 · Cited by 594 · cited 1×
“…and hippocampus, because several studies have shown that chronic exposure to exogenous CORT induces morphological alterations similar to those observed in MDD in these key brain regions implicated in the pathology of depressive disorder (Woolley et al., 1990; Watanabe et al., 1992; Wellman, 2001).”
BackgroundThe coming out of the brain mineralocorticoid receptor
Joëls, M., Karst, H., DeRijk, R., & de Kloet, E. R. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.10.005 · Cited by 481 · cited 1×
“The nongenomic regulation involves binding to MRs or GRs inserted into the presynaptic membrane (Karst et al., 2005; Joëls et al., 2008; Joëls et al., 2009; Wang and Wang 2009).”
BackgroundFeyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421 · cited 2×
“Immunoblotting and data analysis Western blot experiments were performed as described in our previous studies (Feyissa et al., 2009; Feyissa et al., 2010). mGluR5 was labeled using anti-mGluR5 rabbit polyclonal antibody (1:2000; Millipore, Temecula, CA, USA; no.”
MethodSelf-citationDeschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.09111607 · Cited by 278
Self-citationA History of Corticosterone Exposure Regulates Fear Extinction and Cortical NR2B, GluR2/3, and BDNF
Gourley, S. L., Kedves, A. T., Olausson, P., & Taylor, J. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.123 · Cited by 218 · cited 2×
“…following repeated CORT injections is consistent with previous findings indicating that chronic exogenous CORT influences extracellular glutamate levels and regulates expression of glutamate signaling markers (Venero and Borrell 1999; Autry et al., 2006; Gourley et al., 2009; Hunter et al., 2009).”
ResultMood disorders: Regulation by metabotropic glutamate receptors
Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.021 · Cited by 163 · cited 1×
“…as potential biomarkers for depression, and are attractive targets for the discovery of novel antidepressant medications (see Palucha and Pilc, 2007; Witkin et al., 2007; Pilc et al., 2008; Sanacora et al., 2008; Hashimoto, 2009; Sanacora, 2009; Valentine and Sanacora, 2009 for reviews).”
Background
Cited by
Borsook, D., Maleki, N., Becerra, L., & McEwen, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.01.001 · Cited by 367
Dysfunctional hippocampal activity affects emotion and cognition in mood disorders
Femenía, T., Gómez-Galán, M., Lindskog, M., & Magara, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.053 · Cited by 143
Esterlis, I., Holmes, S. E., Sharma, P., Krystal, J. H., & DeLorenzo, C. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.025 · Cited by 50
The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders
(2023) · International Review of Neurobiology · doi:10.1016/bs.irn.2022.10.007 · Cited by 8
Metadata
- Authors
- Iyo, A. H., Feyissa, A. M., Chandran, A., Austin, M. C., Regunathan, S., & Karolewicz, B.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 169
- Issue
- 4
- Pages
- 1567-1574
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2069175484
- Cited by
- 37
- References
- 11
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus. https://app.cochat.ai/papers/10.1016/j.neuroscience.2010.06.023
- The paper
- Iyo, A. H., Feyissa, A. M., Chandran, A., Austin, M. C., Regunathan, S., & Karolewicz, B. (2010). Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus. Neuroscience. https://doi.org/10.1016/j.neuroscience.2010.06.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.